Capillary rarefaction in treated and untreated hypertensive subjects.

Therapeutic Advances in Cardiovascular Disease
Cynthia ChengBonita Falkner

Abstract

This study aimed to determine if capillary rarefaction is detectable and associated with endothelial dysfunction in persons with mild systolic blood pressure (SBP) elevation. Capillary density and endothelial function were quantified for 150 nondiabetic participants, grouped by blood pressure (BP) as normotensive, untreated high BP, and treated high BP. Structural capillary rarefaction measures were not different between the three groups. Functional capillary rarefaction measures were significantly lower in both high BP groups compared to normotensives, and correlated inversely with endothelial function. The study findings indicate that the hypertensive vascular pathologic process is already underway at modest levels of blood pressure elevation.

References

Apr 16, 1999·Hypertension·T F AntoniosG A MacGregor
Oct 20, 1999·Drugs·E Vicaut
Aug 19, 2000·Annals of Medicine·O T Raitakari, D S Celermajer
Jan 3, 2001·British Journal of Clinical Pharmacology·A C Shore
Aug 8, 2001·Circulation·B I LevyH A Struijker-Boudier
Jan 17, 2002·The New England Journal of Medicine·R S VasanD Levy
May 22, 2002·JAMA : the Journal of the American Medical Association·Tien Yin WongUNKNOWN ARIC Investigators
Feb 18, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Piero O BonettiAmir Lerman
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Sep 19, 2003·Pathophysiology of Haemostasis and Thrombosis·P Poredos
Oct 3, 2003·Journal of the American College of Cardiology·Michael E WidlanskyJoseph A Vita
Oct 15, 2003·Circulation·Damiano RizzoniEnrico Agabiti-Rosei
Jun 17, 2004·Circulation·Jean Davignon, Peter Ganz
May 27, 2005·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·M T Schram, C D A Stehouwer
Jul 28, 2005·Annals of Family Medicine·Heather A LiszkaBrent M Egan
Dec 29, 2005·Hypertension·M Kamran IkramPaulus T V M de Jong
Mar 16, 2006·The New England Journal of Medicine·Stevo JuliusUNKNOWN Trial of Preventing Hypertension (TROPHY) Study Investigators
May 2, 2006·American Journal of Hypertension·Haythem DebbabiEduardo Tibiriçà
May 2, 2006·American Journal of Hypertension·Tarek Francis Antonios
Oct 25, 2006·Hypertension·François FeihlBernard I Levy
Feb 6, 2007·Current Opinion in Pharmacology·Edouard J BattegayRok Humar
Jan 1, 2007·Journal of the American Society of Hypertension : JASH·Jay N Cohn

❮ Previous
Next ❯

Citations

Aug 21, 2010·Journal of Hypertension·Cynthia ChengBonita Falkner
Apr 11, 2015·Clinical Kidney Journal·Alcia Edwards-RichardsCarolyn L Abitbol
Nov 5, 2016·The Journal of Clinical Hypertension·Agnes JumarRoland E Schmieder
Dec 10, 2016·PloS One·Agnes JumarRoland E Schmieder
Dec 23, 2017·BMC Cardiovascular Disorders·Agnes J BoschRoland E Schmieder
Nov 22, 2013·American Journal of Physiology. Cell Physiology·Jamie R Karcher, Andrew S Greene

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

Clinical and Translational Science
Cynthia ChengBonita Falkner
American Journal of Hypertension
Haythem DebbabiEduardo Tibiriçá
Microcirculation : the Official Journal of the Microcirculatory Society, Inc
Jerome AellenBernard Waeber
Scandinavian Journal of Clinical and Laboratory Investigation
E RubenowitzL Wilhelmsen
American Journal of Hypertension
Annemieke M V EveleinCuno S P M Uiterwaal
© 2021 Meta ULC. All rights reserved